| Q64949107 | Association between Sedative-hypnotics and Subsequent Cancer in Patients with and without Insomnia: A 14-year Follow-up Study in Taiwan. |
| Q28391051 | Associations between rotating night shifts, sleep duration, and telomere length in women |
| Q42367524 | Associations of melatonin receptor gene polymorphisms with Graves' disease |
| Q28537709 | Characterization of chemically induced ovarian carcinomas in an ethanol-preferring rat model: influence of long-term melatonin treatment |
| Q80495277 | Chronodisruption and cancer |
| Q26798258 | Circadian disruption and breast cancer: an epigenetic link? |
| Q35745008 | Circadian disruption-induced microRNAome deregulation in rat mammary gland tissues |
| Q27690794 | Common sense: folk wisdom that ethnobiological and ethnomedical research cannot afford to ignore. |
| Q37348377 | Dietary correlates of urinary 6-sulfatoxymelatonin concentrations in the Nurses' Health Study cohorts |
| Q21245648 | Does architectural lighting contribute to breast cancer? |
| Q58524770 | Exercise-induced stress enhances mammary tumor growth in rats: Beneficial effect of the hormone melatonin |
| Q39208543 | Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma |
| Q35858998 | Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin |
| Q44284930 | Genetic Variations of Melatonin Receptor Type 1A are Associated with the Clinicopathologic Development of Urothelial Cell Carcinoma |
| Q38495819 | Genome-wide profiling in melatonin-exposed human breast cancer cell lines identifies differentially methylated genes involved in the anticancer effect of melatonin |
| Q38093780 | Health consequences of shift work and implications for structural design |
| Q35217008 | Interactions between environmental factors and melatonin receptor type 1A polymorphism in relation to oral cancer susceptibility and clinicopathologic development |
| Q39542369 | Invited commentary: Shift work and cancer. |
| Q43241340 | Light intensity exposure, sleep duration, physical activity, and biomarkers of melatonin among rotating shift nurses |
| Q34438693 | Melatonin Attenuates Her-2, p38 MAPK, p-AKT, and mTOR Levels in Ovarian Carcinoma of Ethanol-Preferring Rats |
| Q51715991 | Melatonin Inhibits CXCL10 and MMP-1 Production in IL-1β-Stimulated Human Periodontal Ligament Cells. |
| Q33624518 | Melatonin Reduces Angiogenesis in Serous Papillary Ovarian Carcinoma of Ethanol-Preferring Rats |
| Q92083493 | Melatonin and (-)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer |
| Q36076041 | Melatonin and oral cavity |
| Q39629766 | Melatonin and vitamin D3 synergistically down‐regulate Akt and MDM2 leading to TGFβ‐1‐dependent growth inhibition of breast cancer cells |
| Q35066004 | Melatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancer |
| Q37858342 | Melatonin in experimental seizures and epilepsy. |
| Q54224159 | Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-κB DNA-binding activity. |
| Q36551143 | Melatonin inhibits the expression of vascular endothelial growth factor in pancreatic cancer cells |
| Q99567576 | Melatonin on hypothyroidism and gonadal development in rats: a review |
| Q39474556 | Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor expression |
| Q49323107 | Melatonin represses oral squamous cell carcinoma metastasis by inhibiting tumor-associated neutrophils |
| Q38730168 | Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways |
| Q33624824 | Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis |
| Q36282840 | Melatonin, aging, and age-related diseases: perspectives for prevention, intervention, and therapy |
| Q33624917 | Melatonin: A Review of Its Potential Functions and Effects on Dental Diseases |
| Q37755679 | Melatonin: a multitasking molecule |
| Q28387301 | Melatonin: a novel indolamine in oral health and disease |
| Q36835794 | Melatonin: potential functions in the oral cavity. |
| Q38046127 | Molecular mechanisms of melatonin's inhibitory actions on breast cancers. |
| Q48419835 | Pineal gland function is required for colon antipreneoplastic effects of physical exercise in rats. |
| Q38803216 | Potential pleiotropic beneficial effects of adjuvant melatonergic treatment in posttraumatic stress disorder |
| Q39574224 | Role of CD4+ CD25+ regulatory T cells in melatonin-mediated inhibition of murine gastric cancer cell growth in vivo and in vitro |
| Q28397062 | Shift work: health, performance and safety problems, traditional countermeasures, and innovative management strategies to reduce circadian misalignment |
| Q34490935 | Short duration of sleep increases risk of colorectal adenoma |
| Q46678495 | Should we control the pineal status of patients following brain radiotherapy? |
| Q35738439 | Sleep duration and cancer risk in women |
| Q64946860 | The Association Between Sleep Disorders and the Risk of Colorectal Cancer in Patients: A Population-based Nested Case-Control Study. |
| Q47641834 | The Potential of Phytomelatonin as a Nutraceutical. |
| Q35753913 | The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial |
| Q39249477 | The modulatory effect of melatonin on genotoxicity of irinotecan in healthy human lymphocytes and cancer cells. |
| Q98177938 | The role of melatonin in colorectal cancer treatment: a comprehensive review |
| Q38169160 | Therapeutic actions of melatonin on gastrointestinal cancer development and progression |
| Q37210222 | Update on the role of melatonin in the prevention of cancer tumorigenesis and in the management of cancer correlates, such as sleep-wake and mood disturbances: review and remarks. |
| Q24676430 | Violet and blue light blocking intraocular lenses: photoprotection versus photoreception |